Hay Annette Elizabeth, Lawrie Alastair, Robinson Nicolas, Dong Bin, Culligan Dominic J
Department of Haematology, NHS Grampian, Scotland; NCIC Clinical Trials Group, Kingston, Canada.
J Clin Apher. 2013 Oct;28(5):378-80. doi: 10.1002/jca.21274. Epub 2013 Mar 11.
The addition of plerixafor to G-CSF decreases the risk of failed stem cell collection, but at considerable extra cost. Using a logistic regression model based on 354 autologous mobilizations, we have identified a local minimum peripheral blood CD34 count at which the probability of a successful collection is 50%. This seems an appropriate CD34 count at which to add immediate salvage plerixafor.